Research progress in extracorporeal shock wave therapy for upper limb spasticity after stroke.
Haoyang Duan, Yawen Lian, Yuling Jing...
https://pubmed.ncbi.nlm.nih.gov/36846123/Actively Recruiting
Led by Gulf Medical University · Updated on 2026-09-24
50
Participants Needed
1
Research Sites
4 weeks
Total Duration
Stroke is a leading cause of death and long-term disability worldwide. Many stroke survivors suffer from spasticity, especially in the upper limb, which causes increased muscle tightness and limits movement. This condition significantly affects daily activities such as dressing, feeding, and personal care. Traditional treatments like oral medications and botulinum toxin injections have limitations, prompting research into new, non-invasive therapies like extracorporeal shock wave therapy ESWT, which may help reduce spasticity with fewer side effects. This trial evaluates the use of ESWT applied to key spastic muscles of the affected upper limb in stroke patients, combined with conventional physiotherapy. Participants are randomly assigned to receive either real ESWT or a sham treatment along with standard rehabilitation exercises including stretching, mobility, strengthening, and functional training. The ESWT protocol involves delivering controlled acoustic waves to specific muscles to modulate muscle tone and support recovery. During the study, participants will be assessed at baseline, after 6 weeks of intervention, and at a 1-month follow-up 10 weeks to measure upper limb function, muscle electrical activation, and muscle force capacity. These evaluations will help determine the effects of ESWT on spasticity and functional improvement. The trial involves structured rehabilitation and monitoring over this period to gather data on treatment outcomes and safety.
CONDITIONS
Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke.
S
Sharmila banu Ali, DPT
R
Ramprasad Muthukrishnan, Phd/
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Gulf Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants receive either extracorporeal shock wave therapy or a sham treatment along with conventional upper limb physiotherapy.
Weekly visits
Duration - 4 weeks
Participants are assessed one month after treatment to evaluate lasting effects on upper limb function and muscle activity.
1 visit
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Haoyang Duan, Yawen Lian, Yuling Jing...
https://pubmed.ncbi.nlm.nih.gov/36846123/Jordan Daniel Silverman, Gustavo Balbinot, Kei Masani...
https://pubmed.ncbi.nlm.nih.gov/34866885/Mina Park, Myoung-Hwan Ko, Sang-Wook Oh...
https://pubmed.ncbi.nlm.nih.gov/31651335/Gulf Medical University
Lead Sponsor